137 related articles for article (PubMed ID: 35764058)
1. A Comparison of Topical Agents for Eschar Removal in a Porcine Model: Bromelain-enriched vs Traditional Collagenase Agents.
Singer AJ; Goradia EN; Grandfield S; Zhang N; Shah K; McClain SA; Sandoval S; Shoham Y
J Burn Care Res; 2023 Mar; 44(2):408-413. PubMed ID: 35764058
[TBL] [Abstract][Full Text] [Related]
2. Rapid and selective enzymatic debridement of porcine comb burns with bromelain-derived Debrase: acute-phase preservation of noninjured tissue and zone of stasis.
Singer AJ; McClain SA; Taira BR; Rooney J; Steinhauff N; Rosenberg L
J Burn Care Res; 2010; 31(2):304-9. PubMed ID: 20182376
[TBL] [Abstract][Full Text] [Related]
3. Development of a porcine hard-to-heal wound model: evaluation of a bromelain-based enzymatic debriding agent.
Shoham Y; Sabbag I; Singer AJ
J Wound Care; 2021 Sep; 30(Sup9a):VIi-VIx. PubMed ID: 34597174
[TBL] [Abstract][Full Text] [Related]
4. Eschar removal by bromelain based enzymatic debridement (Nexobrid
Hirche C; Citterio A; Hoeksema H; Koller J; Lehner M; Martinez JR; Monstrey S; Murray A; Plock JA; Sander F; Schulz A; Ziegler B; Kneser U
Burns; 2017 Dec; 43(8):1640-1653. PubMed ID: 29033046
[TBL] [Abstract][Full Text] [Related]
5. The effects of rapid enzymatic debridement of deep partial-thickness burns with Debrase on wound reepithelialization in swine.
Singer AJ; Taira BR; Anderson R; McClain SA; Rosenberg L
J Burn Care Res; 2010; 31(5):795-802. PubMed ID: 20661148
[TBL] [Abstract][Full Text] [Related]
6. A Retrospective Review of an Off-label Bromelain-based Selective Enzymatic Debridement (Nexobrid®) in the Treatment of Deep, Partial, and Full Thickness Burns and Hard to Heal Wounds.
Harats M; Haik J; Cleary M; Vashurin I; Aviv U; Kornhaber R
Isr Med Assoc J; 2020 Feb; 22(2):83-88. PubMed ID: 32043324
[TBL] [Abstract][Full Text] [Related]
7. Chemical debridement of burns: mercaptans.
Levenson SM; Gruber DK; Gruber C; Lent R; Seifter E
J Trauma; 1981 Aug; 21(8):632-44. PubMed ID: 7265335
[TBL] [Abstract][Full Text] [Related]
8. Reepithelialization of mid-dermal porcine burns after rapid enzymatic debridement with Debrase®.
Singer AJ; Taira BR; Anderson R; McClain SA; Rosenberg L
J Burn Care Res; 2011; 32(6):647-53. PubMed ID: 21979853
[TBL] [Abstract][Full Text] [Related]
9. Development of a contaminated ischemic porcine wound model and the evaluation of bromelain based enzymatic debridement.
Singer AJ; Toussaint J; Chung WT; McClain SA; Clark RAF; Asculai E; Geblinger D; Rosenberg L
Burns; 2018 Jun; 44(4):896-904. PubMed ID: 29661553
[TBL] [Abstract][Full Text] [Related]
10. Selectivity of a bromelain based enzymatic debridement agent: a porcine study.
Rosenberg L; Krieger Y; Silberstein E; Arnon O; Sinelnikov IA; Bogdanov-Berezovsky A; Singer AJ
Burns; 2012 Nov; 38(7):1035-40. PubMed ID: 22385643
[TBL] [Abstract][Full Text] [Related]
11. Clinical Value of Debriding Enzymes as an Adjunct to Standard Early Surgical Excision in Human Burns: A Systematic Review.
Salehi SH; Momeni M; Vahdani M; Moradi M
J Burn Care Res; 2020 Nov; 41(6):1224-1230. PubMed ID: 32424404
[TBL] [Abstract][Full Text] [Related]
12. A novel rapid and selective enzymatic debridement agent for burn wound management: a multi-center RCT.
Rosenberg L; Krieger Y; Bogdanov-Berezovski A; Silberstein E; Shoham Y; Singer AJ
Burns; 2014 May; 40(3):466-74. PubMed ID: 24074719
[TBL] [Abstract][Full Text] [Related]
13. Enzymatic debridement of deeply burned faces: Healing and early scarring based on tissue preservation compared to traditional surgical debridement.
Schulz A; Fuchs PC; Rothermundt I; Hoffmann A; Rosenberg L; Shoham Y; Oberländer H; Schiefer J
Burns; 2017 Sep; 43(6):1233-1243. PubMed ID: 28363663
[TBL] [Abstract][Full Text] [Related]
14. A Questionnaire-Based Study to Obtain a Consensus from 5 Polish Burns Centers on Eschar Removal by Bromelain-Based Enzymatic Debridement (Nexobrid®) in Burns Following the 2020 Updated European Consensus Guidelines.
Korzeniowski T; Strużyna J; Chrapusta AM; Krajewski A; Kucharzewski M; Piorun K; Nowakowski J; Surowiecka A; Kozicka M; Torres K
Med Sci Monit; 2022 Jan; 28():e935632. PubMed ID: 35064095
[TBL] [Abstract][Full Text] [Related]
15. Helpful hints in deciding what and when to operate after enzymatic debridement.
Claes KEY; De Decker I; Monstrey S; Shoham Y; Vyncke T; Depypere B; De Wolf E; Decuypere F; Lannau B; Hoeksema H
Burns; 2023 Feb; 49(1):80-90. PubMed ID: 35177282
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic uses of pineapple-extracted bromelain in surgical care - A review.
Muhammad ZA; Ahmad T
J Pak Med Assoc; 2017 Jan; 67(1):121-125. PubMed ID: 28065968
[TBL] [Abstract][Full Text] [Related]
17. Eschar removal by bromelain based enzymatic debridement (Nexobrid®) in burns: European consensus guidelines update.
Hirche C; Kreken Almeland S; Dheansa B; Fuchs P; Governa M; Hoeksema H; Korzeniowski T; Lumenta DB; Marinescu S; Martinez-Mendez JR; Plock JA; Sander F; Ziegler B; Kneser U
Burns; 2020 Jun; 46(4):782-796. PubMed ID: 32241591
[TBL] [Abstract][Full Text] [Related]
18. Enzymatic wound debridement.
Ramundo J; Gray M
J Wound Ostomy Continence Nurs; 2008; 35(3):273-80. PubMed ID: 18496083
[TBL] [Abstract][Full Text] [Related]
19. Bromelain-based enzymatic debridement of e-cigarette burns: a single unit experience.
Ho W; Jones CD; Widdowson D; Bahia H
J Wound Care; 2019 Nov; 28(11):758-761. PubMed ID: 31721672
[TBL] [Abstract][Full Text] [Related]
20. Enzymatic frostbite eschar debridement by bromelain.
Ahle NW; Hamlet MP
Ann Emerg Med; 1987 Sep; 16(9):1063-5. PubMed ID: 3307553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
